TP53 and cancer: Our recent studies have shown that heterozygous deletion of TP53 in human colorectal cancer frequently encompasses a neighboring essential gene POLR2A, rendering cancer cells with heterozygous loss of TP53 susceptible to further inhibition of POLR2A22,23.